Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-02T02:54:16.195Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine in patients with NMS

Published online by Cambridge University Press:  02 January 2018

Adityanjee
Adityanjee*
Affiliation:
The Maudsley Hospital, Denmark Hill, London SE5 8AZ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 159 , Issue 2 , August 1991 , pp. 294
Copyright
Copyright © 1991 The Royal College of Psychiatrists 

References

DasGupta, K. & Young, A. (1991) Clozapine-induced neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 52, 105–107.Google Scholar
Muller, T., Becker, T. & Fritze, J. (1988) Neuroleptic malignant syndrome plus carbamazepine. Lancet, 31, 1499–1500.Google Scholar
Pope, H. G., Cole, J. O., Choras, P. T., et al (1986) Apparent neuroleptic malignant syndrome with clozapine and lithium. Journal of Nervous and Mental Diseases, 174, 493–495.Google Scholar
Van Tol, H. H. M., Bunzow, J. R., Guan, H. C. et al (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610–614.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.